0.06 | 1.39%
| Price and Volume | |
|---|---|
| Recent Price | 4.38 |
| 52 Week High | 7.70 |
| 52 Week Low | 3.61 |
| Avg. Daily Vol. (Mil) | 0.08 |
| Beta (3 year) | 0.74 |
| Share Related Items | |
| Mkt Cap (Mil) | 109.33 |
| Shares Out (Mil) | 24.96 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.80 |
| Current Ratio | 2.00 |
| LT Debt/ Equity | 0.07 |
| Total Debt / Equity | 0.14 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 3.35 |
| Price/Book | 3.67 |
| Price/Cash Flow | -20.10 |
| Per Share Data | |
| Earnings | -0.36 |
| Sales | 1.31 |
| Book Value | 1.19 |
| Cash Flow | -0.22 |
| Business Summary | |
|---|---|
| Flamel Technologies, S.A. is a biopharmaceutical company mainly engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications. | |
| General Information | |
| Parc Club du Moulin a Vent
33 Avenue du Docteur Georges Venissieux, 69693 |
|
| www.flamel.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 267 | |
| CEO: Mr. Michael S. Anderson | |
| Short Interest | |
| Current Month (Mil) | 0.13 |
| Previous Month (Mil) | 0.13 |
| Short Interest Ratio (Days) | 5.40 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -12.60 |
| Return on Investments | -27.00 |
| Profitability | |
| Gross Margin | 91.00 |
| EBIT Margin | -26.10 |
| Profit Margin | -26.90 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.30
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet